Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
- 24 April 2007
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 115 (16), 2196-2207
- https://doi.org/10.1161/circulationaha.106.675991
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human plateletsBiochemical Journal, 2006
- Effect of Enteric Coating on Antiplatelet Activity of Low-Dose Aspirin in Healthy VolunteersStroke, 2006
- The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid raftsProceedings of the National Academy of Sciences of the United States of America, 2006
- Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trialAmerican Heart Journal, 2006
- De Novo Synthesis of Cyclooxygenase-1 Counteracts the Suppression of Platelet Thromboxane Biosynthesis by AspirinCirculation Research, 2006
- Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled TrialsThe American Journal of Cardiology, 2005
- Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosisJournal of the American College of Cardiology, 2005
- Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?American Heart Journal, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986